Here you can see and modify the cookie settings of various tools used on and related subdomains.

Save settings
Advantage Austria Show navigation

Austrian start-up mySugr is set to become part of Roche 


Founded in Vienna in 2012, mySugr specialises in providing comprehensive care for people with diabetes. The health tech start-up is now taking its international growth to the next level.

Five years after its launch, mySugr is set to become part of Roche, the international pharmaceuticals concern with which it has been working in close partnership since 2014. mySugr will be 100% owned by Roche, but will continue to exist as a separate company. In future, the firm will form the centrepiece of a new patient-orientated digital health strategy from Roche Diabetes Care. The new capital is due to go primarily into research and product development.

The Austrian startup’s mySugr app currently has some 1 million users, and allows blood sugar levels and other important information to be recorded in a digital diary. mySugr considers itself a global market leader in this area, and the app is available in 52 countries and 13 languages. The mySugr platform is also compatible with all leading diabetes systems and services. In future, users will also have an option to automatically upload their blood sugar readings from their glucose meter of choice to the mySugr diabetes diary app, so they can share their data with doctors and other medical professionals.

mySugr’s 47-strong team is set to expand to over 200 in the next few years, and the company sees considerable potential in building up a complete range of services for diabetics. Specifically, it is working with insurers to sell packages consisting of a blood glucose meter, access to the app, blood sugar test strips and integrated diabetes coaching via the user’s smartphone. Customers of Bavaria’s public sector insurance group can already take advantage of the new product and recoup the cost, and other insurance bodies are due to follow. With more than 400 million people affected by diabetes worldwide, there is significant room to grow.